GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.51 $7.24 Wednesday, 17th Apr 2024 AFMD stock ended at $5.23. This is 2.61% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 3.24% from a day low at $5.20 to a day high of $5.37.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
2022-02-07 $39.00 $41.30 $38.90 $41.20 99 360
2022-02-04 $38.90 $39.60 $37.35 $38.90 129 280
2022-02-03 $39.20 $39.20 $37.80 $38.40 76 880
2022-02-02 $42.40 $42.70 $39.40 $39.60 68 620
2022-02-01 $41.10 $43.10 $40.55 $42.10 141 920
2022-01-31 $38.60 $41.25 $38.60 $40.80 160 450
2022-01-28 $36.90 $38.60 $35.90 $38.50 110 450
2022-01-27 $40.40 $40.55 $36.70 $36.90 135 730
2022-01-26 $40.10 $42.20 $39.30 $39.80 196 120
2022-01-25 $40.30 $40.80 $38.60 $39.60 82 640
2022-01-24 $40.00 $41.20 $37.50 $40.90 192 280
2022-01-21 $40.80 $42.00 $40.20 $40.20 106 290
2022-01-20 $43.20 $44.40 $41.30 $41.40 60 540
2022-01-19 $42.50 $44.18 $42.50 $42.60 95 120
2022-01-18 $43.90 $43.90 $42.10 $42.20 93 890
2022-01-14 $43.60 $44.50 $42.00 $44.40 99 020
2022-01-13 $45.20 $46.00 $43.35 $44.10 168 340
2022-01-12 $47.20 $48.40 $44.70 $44.70 108 960
2022-01-11 $47.40 $49.00 $46.70 $47.20 128 680
2022-01-10 $47.60 $49.20 $45.30 $47.20 145 610
2022-01-07 $50.20 $51.70 $48.10 $48.20 155 100
2022-01-06 $49.70 $51.10 $48.35 $50.40 119 140
2022-01-05 $53.00 $53.70 $49.55 $49.70 103 340
2022-01-04 $56.80 $56.90 $53.05 $53.60 78 044
2022-01-03 $55.50 $57.60 $55.20 $56.50 74 302
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT